Quantinno Capital Management LP Abb Vie Inc. Transaction History

Quantinno Capital Management LP

$7.54 Billion
Q3 2024

A detailed history of Quantinno Capital Management LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Quantinno Capital Management LP holds 157,560 shares of ABBV stock, worth $28.4 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

157,560

Previous 102,791 53.28%

Holding current value

$28.4 Million

Previous $17.6 Million 76.48%

% of portfolio

0.41%

Previous 0.32%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $8.97 Million - $10.9 Million	54,769 Added 53.28%	157,560 $31.1 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $118,723 - $138,642	767 Added 0.75%	102,791 $17.6 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $5.72 Million - $6.52 Million	35,789 Added 54.03%	102,024 $18.6 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $729,968 - $822,115	5,305 Added 8.71%	66,235 $10.3 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $2.9 Million - $3.35 Million	21,692 Added 55.28%	60,930 $9.08 Million
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $781,013 - $971,920	-5,894 Reduced 13.06%	39,238 $5.29 Million
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $504,833 - $581,391	3,491 Added 8.38%	45,132 $7.19 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $2.16 Million - $2.59 Million	15,636 Added 60.13%	41,641 $6.73 Million
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $587,168 - $673,443	4,375 Added 20.23%	26,005 $3.49 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $601,261 - $764,400	4,369 Added 25.31%	21,630 $3.31 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $522,376 - $648,122	3,958 Added 29.75%	17,261 $2.8 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $1.43 Million - $1.81 Million	13,303 New	13,303 $1.8 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $602,592 - $724,488	-9,568 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $628,617 - $803,520	9,568 New	9,568 $696,000
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $334,401 - $393,574	-4,335 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $337,479 - $416,203	4,335 New	4,335 $400,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.

Account

Quantinno Capital Management LP Abb Vie Inc. Transaction History